Mind + Muscle

technical minds + legal muscle


dig deep

Defense to Myriad Patent Infringement Claim Now Moved to Patent Trial and Appeal Board

  • 08.20.14
  • Tony Dutra
  • Bloomberg BNA Patent, Trademark & Copyright Law Daily Bulletin

A recent Bloomberg BNA Patent, Trademark & Copyright Law Daily Bulletin highlighted Sterne Kessler’s filing of 11 petitions for inter partes review on behalf of GeneDx, Inc., a subsidiary of BioReference Laboratories, Inc. The petitions challenge 11 different patents Myriad claims were infringed by GeneDx in parallel patent litigation. The patents at issue are related to the BRCA1, BRCA2, and MUTYH genes associated with diagnosing occurrences of breast, ovarian, and colon cancer. The 11 IPR petitions cite prior art that the USPTO failed to consider in the original patent examinations.

Eldora L. Ellison, Ph.D. is the lead attorney on the petitions directed against the BRCA1/2 related patents, and Deborah Sterling, Ph.D. leads the petitions related to the MUTYH related patents.

To read the full article, download the attached PDF.

Related People

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.